表面殺菌剤の世界市場-2023年～2030年

市場概要

表面殺菌剤の世界市場は、2022年に31億米ドルに達し、2030年には57億米ドルに達すると成長が予測されています。世界の表面殺菌剤市場は、予測期間2023-2030年にCAGR 8.1%を示すと予測されます。

病院関連感染症例の増加、製品上市の増加、新しい消毒薬品のイントロダクション、政府の取り組み、除菌に対する意識の高まりなどが、予測期間における表面殺菌剤の世界市場成長を後押しすると予想される要因のひとつです。

市場力学

入院患者数の増加が表面殺菌剤市場の成長を牽引

入院患者数の増加により、表面消毒の必要性が高まっていることが、予測期間における表面殺菌剤市場の世界成長を後押しすると予想されます。例えば、米国保健協会の2022年のデータによると、2022年の入院患者数はおよそ33,356,853人でした。これらの入院の多くは、慢性疾患や心臓バイパス手術のような重要な処置によるものです。

政府からの資金提供の増加は、世界の表面殺菌剤市場に成長機会をもたらすと予想

ヘルスケアシステムを強化するための政府からの資金提供の増加は、世界の表面殺菌剤市場に有望な成長機会をもたらすと推定されます。例えば、インド政府は、同国のヘルスケア・インフラを拡大するため、5,000億ルピー（68億米ドル）相当の信用奨励プログラムを提示する準備を進めています。

厳しい規制機関の存在が予測期間中の世界表面殺菌剤市場の妨げになると予測

新たに開発された表面殺菌剤の承認に厳しい規制機関が存在することが、予測期間中の世界市場の成長を妨げています。例えば、消毒剤の登録サービスは、中央医薬品標準管理機構（CDSCO）による医薬品および化粧品法の下で管理されており、消毒剤を登録するためには、医薬品に関連するすべての条例を遵守する必要があります。

COVID-19影響分析

COVID-19のパンデミックと世界各国での封鎖により、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局（FDA）は、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準（GCP）を遵守し、試験の完全性に対するリスクを最小限に抑えるための一般的な考慮事項を含むガイドラインを発表しました。

ロシア・ウクライナ紛争影響分析

ロシア・ウクライナ紛争は、スポーツ傷害の発生率が低く、この地域の主要市場プレーヤーが不足しているため、世界の表面殺菌剤市場に中程度の影響を及ぼすと考えられます。ウクライナの診療所は、ロシア軍からの侵攻に耐え続けているもの、死者数の増加と限られた医療援助に追われています。医薬品はあらゆる製品で不足しています。ここでも、基礎資材の輸出入の重要性が、予測期間中の世界表面殺菌剤市場の成長に若干の影響を与えると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第4章 エグゼクティブサマリー

第5章 市場力学

• 影響要因
  • 促進要因
    • 発展の増加
    • 病院内感染の増加
  • 抑制要因
    • 厳しい規制当局
  • 機会
    • 意識の高まり
  • 影響分析

第6章 COVID-19分析

第7章 製品別

• 第4級アンモニウム化合物（QACs）
• 過酢酸
• 過酸化水素
• フェノール
• アルコール
• 次亜塩素酸ナトリウム
• 次亜塩素酸塩
• その他

第8章 製剤別

• ワイプ
• スプレー
• 液体

第9章 エンドユーザー別

• 病院・クリニック
• 外来外科センター
• レストラン・フードチェーン
• 一般家庭
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他アジア太平洋地域
• 中東およびアフリカ
  • 主な地域別ダイナミクス

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Procter & Gamble
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Reckitt Benckiser Group plc.
• Carroll Company
• Cantel Medical Corporation
• UPS Hygiene Pvt. Ltd.
• Metrex Research, LLC.
• STERIS plc.
• Whiteley Corporation
• PURE Bioscience, Inc.
• Henkel AG

第13章 付録

Market Overview

The Global Surface Disinfectants Market reached US$ 3.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.7 billion by 2030. The global Surface Disinfectants market is expected to exhibit a CAGR of 8.1% during the forecast period 2023-2030.

The increase in the number of hospital-associated infection cases, rising product launches, introductions of new disinfectant chemicals, government initiatives, and increasing awareness about sanitization are among the factors expected to boost the global surface disinfectants market growth in the forecast period.

Market Dynamics

Increasing Number Of Hospital Admission Drive The Growth Of The Surface Disinfectants Market.

The increasing number of hospital admission are leading to an increased requirement for surface disinfection is expected to boost the global surface disinfectant market growth in the forecast period. For instance, according to 2022 data from the American Health Association, there were roughly 33,356,853 hospital admissions in 2022. Many of these admissions were due to chronic diseases and critical procedures like heart bypass surgery.

The Increasing Funding From The Government Is Expected To Present The Global Surface Disinfectants Market With Growth Opportunities.

The increasing funding from the government to boost the healthcare system is estimated to present the global surface disinfectant market with prospective growth opportunities. For instance, the Indian government is preparing to present a credit incentive program worth Rs. 500 billion (US$ 6.8 billion) to expand the country's healthcare infrastructure.

The Presence of Stringent Regulatory Bodies is Estimated To Hamper The Global Surface Disinfectants Market During The Forecast Period.

The presence of stringent regulatory bodies for the approval of newly developed surface disinfectants is hampering the global market growth in the forecast period. For instance, the disinfectant registration services are controlled under Drug and Cosmetics Act by The Central Drugs Standard Control Organisation (CDSCO) and all ordinances relevant to drugs are required to be obeyed for enlisting disinfectants.

COVID-19 Impact Analysis.

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis.

The Russia-Ukraine conflict is thought to hold a moderate influence on the global Surface Disinfectants market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global surface disinfectants market growth in the forecast period.

Segment Analysis

The Global Surface Disinfectants Market is segmented based on product, formulation, end-user, and region.

The Hospital End-User Segment is Estimated to Dominate the Global Surface Disinfectants Market.

With the increasing growth in the number of hospitals, the hospital end-user segment is estimated to hold about 38.5% of the global market by 2030. For instance, India is home to more than 69,000 public and private hospitals, comprising nearly 1.8 million beds. The country provides free healthcare services through its public health system governed independently by individual states and union territories.

Geographical Analysis

Europe is Estimated to Hold 27.7% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region.

Owing to the increased healthcare expenditure and utilization the European surface disinfectant market is estimated to hold about 27.7% of the global market share. For instance, according to the EuStats, there were more than 8,670 hospital discharges per 100,000 inhabitants in Albania in 2021, the most inferior percentage of in-patient discharges comparable to inhabitants proportions in the region, it was 4 % down corresponded to 2011.

Kosovo registered more than 8,815 hospital discharges per 100 000 inhabitants in 2021. In 2021 public expenditure on health in the EU was assessed at 8.8 % of GDP, while whole expenditure amounted to 10.9 %. This stood more elevated than in all the Western Balkans and Turkiye. In 2021, expenditure on health and the percentage of public health expenditure grew by 0.9% points each corresponding to 2011.

Competitive Landscape

The major global players in the market include: Procter & Gamble, Reckitt Benckiser Group plc., Carroll Company, Cantel Medical Corporation, UPS Hygiene Pvt. Ltd., Metrex Research, LLC., STERIS plc., Whiteley Corporation, PURE Bioscience, Inc. and Henkel AG, among others.

Why Purchase the Report?

• To visualize the Global Surface Disinfectants Market segmentation based on product, formulation, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous surface disinfectant market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.

The Global Surface Disinfectants Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Industry Analysis

• 3.1. Porter's 5 Forces Analysis
• 3.2. Supply Chain Analysis
• 3.3. Pricing Analysis
• 3.4. Regulatory Analysis

4. Executive Summary

• 4.1. Snippet by Product
• 4.2. Snippet by Formulation
• 4.3. Snippet by End User
• 4.4. Snippet by Region

5. Dynamics

• 5.1. Impacting Factors
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Market Developments
    • 5.1.1.2. Growing Cases of Hospital-Acquired Infections
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent Regulatory Authorities
  • 5.1.3. Opportunity
    • 5.1.3.1. Increasing Awareness
  • 5.1.4. Impact Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Quaternary Ammonium Compounds (QACs) *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Peracetic Acid
• 7.4. Hydrogen Peroxide
• 7.5. Phenol
• 7.6. Alcohol
• 7.7. Sodium Hypochlorite
• 7.8. Hypochlorite
• 7.9. Others

8. By Formulation

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 8.1.2. Market Attractiveness Index, By Formulation
• 8.2. Wipes *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Sprays
• 8.4. Liquids

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals & Clinics *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Outpatient Surgical Centers
• 9.4. Restaurants & Food Chains
• 9.5. Households
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. The U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan

Australia

• 10.5.6.4. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Procter & Gamble *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Reckitt Benckiser Group plc.
• 12.3. Carroll Company
• 12.4. Cantel Medical Corporation
• 12.5. UPS Hygiene Pvt. Ltd.
• 12.6. Metrex Research, LLC.
• 12.7. STERIS plc.
• 12.8. Whiteley Corporation
• 12.9. PURE Bioscience, Inc.
• 12.10. Henkel AG

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us